Advertisement

Health


LuminaX Healthtech Accelerator accepts record cohort of founders for 2024

LuminaX Healthtech Accelerator accepts record cohort of founders for 2024

The Gold Coast’s LuminaX HealthTech Accelerator has accepted ...

Zea Relief gets a healthy boost to its retail footprint through Woolworths distribution deal

Zea Relief gets a healthy boost to its retail footprint through Woolworths distribution deal

Zea Relief, a Tasmanian wellness scale-up that has developed a rang...

AI medtech Artrya secures first Australian commercial agreement with The Cardiac Centre NSW

AI medtech Artrya secures first Australian commercial agreement with The Cardiac Centre NSW

Perth-based medtech Artrya (ASX: AYA) has secured the first commerc...

Australia’s biggest chemist is merging with a giant wholesaler. Could we soon be paying more?

Australia’s biggest chemist is merging with a giant wholesaler. Could we soon be paying more?

Corporate Australia loves a big merger. And amid a growing flurry o...

Genesis Capital lifts Pacific Smiles takeover bid to $279 million

Genesis Capital lifts Pacific Smiles takeover bid to $279 million

Pacific Smiles (ASX: PSQ) suitor Genesis Capital has brus...

Advertisement
Advertisement
Advertisement
Creso Pharma appoints director of US business after New York legalises marijuana

Creso Pharma appoints director of US business after New York legalises marijuana

Australian medicinal cannabis company Creso Pharma (ASX: CPH) has...

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Stem cell therapeutics company Cynata's (ASX: CYP) pool of el...

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Pharmaceuticals manufacturer Starpharma (ASX: SPL) will commence ...

New US trial finds AstraZeneca vaccine 79 per cent effective

New US trial finds AstraZeneca vaccine 79 per cent effective

A Phase III trial of the AstraZeneca vaccine in the US has demons...

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Buy-now pay-later (BNPL) operator Openpay (ASX: OPY) has announce...

IDT looks to manufacture COVID-19 vaccines on-shore

IDT looks to manufacture COVID-19 vaccines on-shore

Victorian pharmaceuticals manufacturer IDT Australia (ASX: IDT) h...

Centuria to build Melbourne hospital for doctor-led Medicare JV

Centuria to build Melbourne hospital for doctor-led Medicare JV

A subsidiary of Centuria Capital Group (ASX: CNI) has entered a p...

People Infrastructure acquires SwingShift Nurses

People Infrastructure acquires SwingShift Nurses

Workforce management company People Infrastructure (ASX: PPE) con...

Elixinol to bag German CBD brand for $13.9m

Elixinol to bag German CBD brand for $13.9m

Australian cannabis company Elixinol's (ASX: EXL) plans to pu...

Creso Pharma expanding into psychedelics with planned acquisition

Creso Pharma expanding into psychedelics with planned acquisition

Creso Pharma (ASX: CPH) is looking to tap into the emerging psych...

Mesoblast receives $138m injection from US investors

Mesoblast receives $138m injection from US investors

Australian biotechnology company Mesoblast (ASX: MSB) will receiv...

Investors like what they see under Healthia's skin, boosting its value to $185m

Investors like what they see under Healthia's skin, boosting its value to $185m

Allied health company Healthia Limited (ASX: HLA) has almost doub...

Needle-phobes rejoice: NeedleCalm launches in Australia

Needle-phobes rejoice: NeedleCalm launches in Australia

An innovative piece of medical technology aimed at reducing physi...

Medibank profit rises, CEO Craig Drummond to depart

Medibank profit rises, CEO Craig Drummond to depart

Private health insurance provider Medibank (ASX: MPL) has capital...

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Australian pharmaceutical company Starpharma's (ASX: SPL) ant...

Advertisement

Partner Content

Private credit specialist Finexia Financial Group (ASX: FNX) has se...
After relocating his Canberra-founded company Whitefox Recruitment ...
Armed with a growing business and a great opportunity, a business o...
The digital revolution may have changed the office forever, but the...
Private credit specialist Finexia Financial Group (ASX: FNX) has ac...
Environmental engineer Romin Nejad began his career at Epic Environ...
The transition from elite athlete and gymnastics coach to a corpora...
Australasian business solutions company Fusion5 has been honoured w...
Advertisement